Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MEDS will decline by -5.49% over the next 2 Weeks and hit $7.17 by Tuesday, October 29, 2024. In that time frame, MEDS's share price is expected to range between $6.76 and $7.56.
BearishAverageBullishMEDS shares rose +4.55% in Friday, September 20, 2024's trading session, rising from a previous close of $7.26 to move at $7.59. The stock demonstrated notable intraday movement (see MEDS's key stats for a full breakdown), fluctuating between $7.06 and $7.70, a +9.07% trading range. While recent weeks have seen some volatility, MEDS has managed to secure a +3.83% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 2.91K shares changing hands, 5.34K fewer than the previous session. This amounted to $22.06K in total market activity.
Will MEDS Continue Its Downward Trend?
According to analyst ratings and projections for MEDS, TRxADE HEALTH, Inc. shares are anticipated to decrease by -1.23%, potentially reaching $7.50 per share by October 29, 2024. Short-term technical indicators currently suggest a neutral sentiment for MEDS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the MEDS stock forecast, now is not the best time to buy MEDS stock because its current trading price is +7.53% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MEDS covering social and institutional perspectives.
MEDS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MEDS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 41.12% to 43.81%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 47.02%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.58%, maintains a neutral outlook for the long term. Insights into MEDS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
TRxADE HEALTH Short-Term Forecasts
MEDS Forecast For Next 5 Days
Our algorithm anticipates TRxADE HEALTH (MEDS) stock could hit $2.71 by Oct 04, 2024. This represents a -64.34% rise from today's price, following a +3.14% change over the past five days.
MEDS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for TRxADE HEALTH, Inc. (MEDS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.06, which would mean a -59.68% decrease from the current price of $7.59. Projections for this period range from a high of $6.25 to a low of -.
MEDS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for TRxADE HEALTH's price over the next three months point to a drop. MEDS stock is expected to peak at $4.39 on Aug 13, 2025 before potentially dipping to - on Sep 19, 2025. On average, MEDS is likely to trade around $3.77 in the coming 90 days.
TRxADE HEALTH Stock Forecast 2025
Based on our predictive models, TRxADE HEALTH (MEDS) is expected to trade between - and $7.29 throughout 2025. This would result in an average price of $4.06, potentially offering investors a -46.51% return from current levels.
TRxADE HEALTH, Inc. Monthly Forecast 2024–2025
September 2024
According to our latest forecast models, TRxADE HEALTH, Inc. (MEDS) is positioned to show a strong performance in September 2024. The price is predicted to move between $10.21 and $12.21, settling at an average of $11.17. This could translate to a +47.17% gain.
October 2024
Based on current market signals, TRxADE HEALTH, Inc. is projected to trend october 2024. We forecast a trading range from $7.56 to $12.56, with a likely average price of $10.61. Investors could expect a potential return of +39.79%.
November 2024
Our predictive algorithms indicate TRxADE HEALTH, Inc. stock may see a shift in November 2024. The expected range spans $4.70–$9.39, with an average target of $6.51. This represents a cautious outlook and a possible loss of -14.23%.
December 2024
Analyzing established trends, TRxADE HEALTH, Inc. looks set to move in December 2024. Projections place the stock between $4.44 and $7.04, averaging around $5.72. This suggests a -24.64% loss from current levels.
January 2025
Market indicators suggest TRxADE HEALTH, Inc. could experience notable changes during January 2025. Prices could fluctuate within $1.04 to $7.01, with a midpoint forecast of $3.92. The stock might deliver a -48.35% loss.
February 2025
Forecasting for February 2025, models estimate that TRxADE HEALTH, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.08 and $5.18, averaging $3.00. This signals a cautious trajectory with potential returns around -60.47%.
March 2025
According to our latest forecast models, TRxADE HEALTH, Inc. (MEDS) is positioned to show a strong performance in March 2025. The price is predicted to move between $3.35 and $7.29, settling at an average of $5.45. This could translate to a -28.19% loss.
April 2025
Based on current market signals, TRxADE HEALTH, Inc. is projected to trend april 2025. We forecast a trading range from $1.94 to $6.03, with a likely average price of $3.94. Investors could expect a potential return of -48.09%.
May 2025
Our predictive algorithms indicate TRxADE HEALTH, Inc. stock may see a shift in May 2025. The expected range spans $1.90–$5.28, with an average target of $3.70. This represents a cautious outlook and a possible loss of -51.25%.
June 2025
Analyzing established trends, TRxADE HEALTH, Inc. looks set to move in June 2025. Projections place the stock between $1.37 and $5.57, averaging around $3.91. This suggests a -48.48% loss from current levels.
July 2025
Market indicators suggest TRxADE HEALTH, Inc. could experience notable changes during July 2025. Prices could fluctuate within $1.39 to $5.66, with a midpoint forecast of $4.68. The stock might deliver a -38.34% loss.
August 2025
Forecasting for August 2025, models estimate that TRxADE HEALTH, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.25 and $5.38, averaging $4.19. This signals a cautious trajectory with potential returns around -44.80%.
September 2025
According to our latest forecast models, TRxADE HEALTH, Inc. (MEDS) is positioned to show a strong performance in September 2025. The price is predicted to move between $0.00 and $3.87, settling at an average of $3.51. This could translate to a -53.75% loss.
MEDS's history of dividends and stock splits also plays a role in long-term investor confidence.